Acute Myeloid Leukemia Relapsed Adult
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia Relapsed Adult.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 trial of single-agent decitabine in TP53-mutated relapsed/refractory acute myeloid leukemia was terminated with results posted.